US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
COVID-19 and flu activity is increasing in most parts of the country and RSV activity remains very high, especially in young children. Respiratory illness activity in Florida is very high ...
Both Lehigh Valley and St. Luke’s University health networks report increased hospitalizations related to influenza and respiratory syncytial virus, two of the most common respiratory infections ...
It's flu season. And COVID season. And RSV season. The Centers for Disease Control and Prevention (CDC) reported that as of last week, "the amount of acute respiratory illness causing people to ...
Winter is usually accompanied by an uptick in respiratory illnesses, such as Covid-19 and RSV, and 2025 is no exception. For RSV in particular, nearly two dozen states are currently reporting high ...